Department of Nuclear Medicine, La Timone University Hospital, CERIMED, Aix-Marseille University, 264 rue Saint-Pierre, 13005, Marseille Cedex 05, France.
Section on Medical Neuroendocrinology, Eunice Kennedy Shriver National Institutes of Child Health and Human Development, National Institutes of Health, Building 10, CRC, Room 1E-3140, 10 Center Drive MSC-1109, Bethesda, MD, 20892-1109, USA.
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2223-2224. doi: 10.1007/s00259-019-04435-z. Epub 2019 Jul 22.
The EANM/SNMMI 2019 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma (PPGL) describe the current experts' views on molecular imaging in the era of precision medicine, and contain all of the information needed by nuclear physicians for performing, interpreting, and reporting the results of imaging investigations. This editorial, from a clinician's perspective, describes the first-choice radiopharmaceutical for a particular clinical setting as an important element of the revised guidelines. It also gives new evidence-based data showing the steadily growing role of nuclear imaging in PPGL phenotyping and assessment of their clinical characteristics and outcomes.
EANM/SNMMI 2019 年嗜铬细胞瘤和副神经节瘤（PPGL）放射性核素成像指南描述了精准医学时代分子成像的当前专家观点，包含核医学医师进行、解释和报告影像学研究结果所需的所有信息。本社论从临床医生的角度出发，将特定临床环境下的首选放射性药物描述为修订指南的重要组成部分。它还提供了新的基于证据的数据，表明核成像在 PPGL 表型分析以及评估其临床特征和结局方面的作用稳步增长。
